Parker L A, Brosseau L
Department of Psychology, Wilfrid Laurier University, Waterloo, Ontario.
Pharmacol Biochem Behav. 1990 Mar;35(3):583-7. doi: 10.1016/0091-3057(90)90294-r.
Apomorphine is a positively reinforcing drug at low to moderate doses, but appears to lose its reinforcing properties at higher doses. In Experiment 1, across a range of doses (0.5-15.0 mg/kg, intraperitoneally), apomorphine produced a CTA over 5 conditioning/testing trials which was not dose-dependent by a single bottle test. The rejection taste reactivity responses of chin rubbing and gaping, however, only occurred at the highest dose of apomorphine (15 mg/kg). In Experiment 2, a CTA test which was designed to more effectively discriminate among the different drug dose conditions indicated that the doses of 2.5, 7.5 and 15 mg/kg of apomorphine produce CTAs of equivalent strength. Our results support the contention that CTAs produced by positively reinforcing drugs are not accompanied by a palatability shift.
阿扑吗啡在低至中等剂量时是一种具有正性强化作用的药物,但在高剂量时似乎会失去其强化特性。在实验1中,在一系列剂量(0.5 - 15.0毫克/千克,腹腔注射)范围内,阿扑吗啡在5次条件化/测试试验中产生了条件性味觉厌恶反应,通过单瓶试验该反应不具有剂量依赖性。然而,只有在阿扑吗啡最高剂量(15毫克/千克)时才出现了下巴摩擦和张口的排斥性味觉反应。在实验2中,一项旨在更有效区分不同药物剂量条件的条件性味觉厌恶试验表明,2.5、7.5和15毫克/千克剂量的阿扑吗啡产生的条件性味觉厌恶反应强度相当。我们的结果支持这样的观点,即具有正性强化作用的药物产生的条件性味觉厌恶反应并不伴随着适口性的改变。